Prevalence of Herpesvirus 8 infection in type 2 diabetes mellitus patients

American Journal of Infectious Diseases

Volumn 3, Issue 3, 2007, Pages 123-127

  Ingianni, Angela ^a   Carta, F ^a   Reina, A ^b   Manai, M ^c   Desogus, A ^a,d   Pompei, R ^a,d  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b BROTZU HOSPITAL   (Italy)

^c University Hospital San Giovanni di Dio   (Italy)

^d Biotecne   (Italy)

Author keywords

Diabetic complicating diseases; HHV 8; Molecular epidemiology; Type 2 diabetes mellitus

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD DONOR; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HEART MUSCLE ISCHEMIA; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HYPERTENSION; ITALY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; SOUTHERN BLOTTING; VIRUS DETECTION;

EID: 67649891557     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2007.123.127     Document Type: Article

References (17)

1. De Paoli P., 2004. Human herpesvirus 8: an update. Microbes Infect., 6: 328-35.
2. Dodd R.Y., 2005. Human herpesvirus-8: what (not) to do? Transfusion, 45: 463-5.
3. Schulz T.F., 2000. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. J. Antimicrob. Chemother., 45: 15-27.
4. Stewart, J.A., J.L. Patton and E.T. Lennette, 1999. Human Herpesviruses 6, 7 and 8 and Herpes B Virus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH Eds. Manual of Clinical Microbiology. Washington, DC: ASM., pp: 919-27.
5. Brown, E.E., M.D. Fallin and J.J. Goedert et al., 2006. Host Immunogenetics and Control of Human Herpesvirus-8 Infection. J. Infect. Dis., 193: 1054-1062.
6. Stebbing, J., B. Gazzard and M. Bower, 2006. The Host Control of Lytic and Latent Infection with Human Herpesvirus-8. J. Infect. Dis., 193: 1051-1053.
7. Ascoli, V., D. Manno and S. Guzzinati et al., 2002.La puntura di artropodi ematofagi quale possibile cofattore nella trasmissione di HHV8 (Human Herpes Virus 8) e nell'espressione del sarcoma di Kaposi. Ren. Fis. Acc. Lincei, 13: 71-88.
8. Ninfali, P., L. Baronciani and A. Ruzzo et al., 1993. Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara district. Hum. Genet., 92: 139-142.
9. Guttman-Yassky, E., J. Dubnov and Z. Kra-Oz et al., 2006. Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk? Cancer, 106: 413-419.
10. Kataoka, S., J. Satoh and H. Fujiya, et al., 1983. Immunologic aspects pf the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes, 32: 247-253.
11. Chiou, C.C., W.H. Chung and S.I. Hung et al., 2006. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human hepesvirus 6 infection. J.Am. Acad. Dermatol., 54: S14-17
12. Hashimoto, K., M. Yasukawa and M. Tohyama, 2003. Human Herpesvirus 6 and drug allergy. Curr.Opin. Allergy Clin. Immunol., 3: 255-260.
13. Borgia, M.C., C. Nandolini and C. Barresi et al., 2001. Further evidence against the implication of active cytomegalovirus infection in vascular atherosclerotic diseases. Atherosclerosis, 157: 457-462.
14. Carletti, F., C. Mandolini and A. Rossi et al., 2002. Prevalence of human herpesvirus (HHV)-8 infection among carriers of cardiovascular diseases. J. Biol. Regul. Homeost. Agents, 16: 110-113.
15. Sepùlveda, M.A., J. Moreu and T. Cantòn et al., 1999. Prevalence of IgG antibodies against Cytomegalovirus in patients with angiographically demonstrated coronary atherosclerosis. Enferm. Infect. Microbiol. Clin., 17: 386-389.
16. Crispo, A., M. Tamburini and M.R. De Marco et al., 2001. HHV-8 prevalence, immunosuppression and Kaposi's sarcoma in South Italy. Int. J. Mol. Med., 7: 535-538.
17. Chang, Y., E. Cesarman and M.S. Pessin et al., 1994. Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's Sarcoma. Science, 266: 1865-1869.